23andMe Holding Co. ME

23andMe Holding Co. is a genetics-led consumer healthcare and biopharmaceutical company. The Company operates through two segments: Consumer & Research Services and Therapeutics. The Consumer & Research Services business segment comprises its Personal Genome Service (PGS), telehealth business, and research service. PGS services provide customers with a broad suite of genetic reports, including information on customers’ genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications. The Therapeutics business segment focuses on the use of genetic insights from databases of genetic and phenotypic information to develop novel therapies to improve patients’ lives. The Therapeutics segment consists of out-licensing of intellectual property associated with identified drug targets and expenses related to therapeutic product candidates.

NDAQ:ME - Post by User

23andMe Holding Co.

<< Previous

Bullboard Posts

Post by whytestockson Oct 17, 2024 6:15pm

24 Views

Post# 36270744

23andMe Introduces New Feature Helping African Americans Tra

JUST IN: $ME 23andMe Introduces New Feature Helping African Americans Trace Their Roots to Post Slavery Communities in the SouthSUNNYVALE, Calif., Oct. 17, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics company, released a powerful new feature that enables African American customers to trace their roots to over 200 communities of people of African descent in the Southern United States....ME - 23andMe Introduces New Feature Helping African Americans Trace Their Roots to Post Slavery Communities in the South

<< Previous

Bullboard Posts

Paramount Resources signs $3.32 billion asset sale